Skip to content
Recall Observatory FDA recall evidence

Drug product

Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.

D-0262-2024

January 10, 2024

Class II

Product summary

Firm
BE PHARMACEUTICALS AG
Event
Event 93747
Status
Terminated
Classification
Class II
Quantity
22,176 Vials
Official record key
drug-enforcement:D-0262-2024

Official wording

Reason: Lack of Sterility Assurance: Aseptic process simulation failure.

Code information: lot #13D012AA, Exp: 08/31/2025

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Sterility